Barcelona, Spain: Trends indicate that survival is improving in patients with metastatic breast cancer, especially in those patients whose tumours are described as being HER2 (human epidermal growth factor receptor-2) positive, a surgical oncologist will say today (Friday 26 March) at the seventh European Breast Cancer Conference (EBCC7). Dr Marie Sundquist, from the Department of […]
Beta-blockers help reduce metastasis and improve survival in breast cancer patients
Barcelona, Spain: Treatment with beta-blockers can help reduce the spread of cancer in patients with breast tumours, a researcher will tell the seventh European Breast Cancer Conference (EBCC7) in Barcelona today (Friday). In a controlled study, Dr. Des Powe, a senior healthcare research scientist at Queen’s Medical Centre, Nottingham University Hospital NHS Trust, Nottingham, UK, […]
Study suggests pregnant women can receive chemotherapy for breast cancer without endangering the health of their babies
Barcelona, Spain: Women who discover they have breast cancer while they are pregnant can be treated with chemotherapy without endangering the health of their unborn baby, according to research to be presented at the seventh European Breast Cancer Conference (EBCC7) in Barcelona today (Friday). Dr Sibylle Loibl, Assistant Professor in Obstetrics and Gynaecology at the […]
Two studies reveal associations between pregnancy, breast-feeding, breast cancer and survival
Barcelona, Spain: Women who are diagnosed with breast cancer in the 12 months after they have completed a pregnancy are 48% more likely to die than other young women with breast cancer according to new research to be presented at the seventh European Breast Cancer Conference (EBCC7) in Barcelona today (Friday). [1] However, the study […]
New studies on surgical options in inherited breast cancer show that drastic treatment is not always best
Barcelona, Spain: Two studies to be presented at the seventh European Breast Cancer Conference (EBCC7) in Barcelona today (Friday) and tomorrow (Saturday), shed light on the treatment options facing women carrying the BRCA1 and BRCA2 genetic mutations which predispose them to breast cancer. In the first, Ms Annette Heemskerk-Gerritsen, a PhD student in the Department […]
Pregnancy for breast cancer survivors: meta-analysis reveals it is safe and could improve survival
Barcelona, Spain: Women who have been treated for breast cancer can choose to become pregnant and have babies, without fears that pregnancy could put them at higher risk of dying from their cancer, according to a major, new study. In a meta-analysis of 14 trials, presented today (Friday) at the seventh European Breast Cancer Conference […]
Patients requesting prophylactic mastectomies overestimate their breast cancer risk and need a ‘cooling off’ period
Barcelona, Spain: Women who have been diagnosed with breast cancer believe the risk of the disease occurring in their unaffected breast is as much as ten times higher than it actually is. As a result, they are choosing to have prophylactic mastectomies based on a false perception of increased risk, according to new research. However, […]
Researchers discover a new way to predict which breast cancer patients should be treated with anthracyclines
Barcelona, Spain: An international team of researchers has discovered a new way of detecting which breast cancer patients are going to respond best to chemotherapy that includes anthracycline antibiotics*. The research, presented at the seventh European Breast Cancer Conference (EBCC7) in Barcelona today (Thursday), is important because, until now, there was conflicting evidence about the […]
What should be the goal of treatment in metastatic breast cancer? Patients and doctors differ in their views
Barcelona, Spain: Many patients with metastatic breast cancer believe that the primary goal in survival with new treatment should be to prolong life by at least a year over the survival they might expect from using current best therapies, a researcher will tell the seventh European Breast Cancer Conference (EBCC7) in Barcelona today (Wednesday). This […]
Greater collaboration between health care providers needed to ensure that breast cancer patients get full benefit from tamoxifen treatment
Barcelona, Spain: Recently published research has shown that some breast cancer patients taking tamoxifen may not be getting the full benefit of their treatment because they have also been taking selective serotonin reuptake inhibitors (SSRIs), prescribed drugs that inhibit the effect of an important enzyme. Now researchers have developed a strategy for overcoming this problem, […]